Currently available methylation diagnostics tests

Dear visitors,

we do not sell any kits or methylation tests at present. The information provided by EpiCell Diagnostics can be used exceptionally for your educational and scientific purposes.

Colorectal cancer

Breast cancer

Cervical cancer

Ovarian cancer

Glioblastoma

Lung cancer

Oral cancer

HCC liver cancer

C1R Prognostic biomarker for acute myeloid leukemia

DNMT3A Epimutation in acute myeloid leukemia

Urine DNA methylation assay for bladder cancer

PRDM8 Biomarker for aplastic anemia and dyskeratosis congenita

Chronomics biological age from buccal swabs

Cygenia® age-prediction blood test

Cygenia® age-prediction buccal swab test

Chronomics AI driven personalized medicine

Epigenetic indicators of metabolic landscape

SKINTELLI® personalized skincare epigenetics kit

GRAIL Galleri® multi-cancer early detection test

Anthracycline-based chemotherapy response with the Therascreen PITX2 breast cancer epigenetic test

Temozolomide resistance methylguanine-DNA-methyltransferase gene methylation detection kit

QIAGEN EGFR circulating-free DNA mutation test for non-small cell lung cancer

ColoAlert® tumor DNA screening test for colorectal cancer

Epigenetic signatures of cigarette smoking

Epigenetic modifications associated with alcohol consumption

Radiation exposure diagnostic kit

Veterinary diagnostic DNA methylation kit

Not necessarily. Many diseases or conditions may be caused by a number of factors. Therefore, it is especially important to continue routine medical preventive care or further epigenetic screenings even if you receive a negative test result. Please, consult with healthcare specialist about results from any negative direct-to-consumer test.

A positive health risk test does not indicate that an individual will obviously develop a given disease or a condition. Many health conditions mentioned above may be caused by several factors including not only epigenetics, but due to inflammatory and oxidative damage, or genetic mutations as well.

Epigenetic risk is a first early sign that may contribute to the development of disease or condition in future. However, you should consult with your healthcare provider about the right steps to take following receiving results, including getting confirmatory traditional health care evaluation, if applicable.